Published in Exp Neurol on March 01, 2005
TNF-alpha and neuropathic pain--a review. J Neuroinflammation (2010) 1.68
Death Receptor 6 Promotes Wallerian Degeneration in Peripheral Axons. Curr Biol (2017) 1.39
A prospective study of secondary degeneration following subcortical infarction using diffusion tensor imaging. J Neurol Neurosurg Psychiatry (2007) 1.31
Mode of action of cytokines on nociceptive neurons. Exp Brain Res (2009) 1.26
Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo. J Neuroinflammation (2013) 0.96
Immediate anti-tumor necrosis factor-alpha (etanercept) therapy enhances axonal regeneration after sciatic nerve crush. J Neurosci Res (2010) 0.91
Reactive oxygen species mediate TNFR1 increase after TRPV1 activation in mouse DRG neurons. Mol Pain (2009) 0.88
The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain. J Pharm Pharmacol (Los Angel) (2013) 0.88
Role of TNF-alpha during central sensitization in preclinical studies. Neurol Sci (2011) 0.87
The ology of neuropathy: an integrative review of the role of neuroinflammation and TNF-α axonal transport in neuropathic pain. J Peripher Nerv Syst (2011) 0.84
LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain. PLoS One (2014) 0.81
CCL2 has similar excitatory effects to TNF-α in a subgroup of inflamed C-fiber axons. J Neurophysiol (2011) 0.78
Cellular therapies for treating pain associated with spinal cord injury. J Transl Med (2012) 0.76
[Cytokine regulation and pain. Results of experimental and clinical research]. Schmerz (2008) 0.75
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain (2015) 3.82
Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci (2003) 2.89
Small fibre pathology in patients with fibromyalgia syndrome. Brain (2013) 2.72
Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain (2010) 2.35
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology (2012) 2.09
Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials. Pain (2009) 1.93
Chronically infused intrathecal morphine in dogs. Anesthesiology (2003) 1.93
Differential expression patterns of cytokines in complex regional pain syndrome. Pain (2007) 1.91
Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp Neurol (2012) 1.81
TNF-α in CRPS and 'normal' trauma--significant differences between tissue and serum. Pain (2010) 1.74
Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum (2006) 1.64
Functional and structural nerve fiber findings in heterozygote patients with Fabry disease. Pain (2009) 1.62
Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA (2009) 1.58
Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain (2013) 1.52
Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol (2010) 1.41
Intravenous immunoglobulin to fight complex regional pain syndromes: hopes and doubts. Ann Intern Med (2010) 1.38
Differential expression of cytokines in painful and painless neuropathies. Neurology (2007) 1.38
A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci (2009) 1.37
Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci (2003) 1.32
Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. J Neurosci (2008) 1.31
T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol (2006) 1.30
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord (2011) 1.30
Mode of action of cytokines on nociceptive neurons. Exp Brain Res (2009) 1.26
Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy. J Peripher Nerv Syst (2011) 1.15
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain (2010) 1.15
Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain (2003) 1.15
Wallerian degeneration after crush injury of rat sciatic nerve increases endo- and epineurial tumor necrosis factor-alpha protein. Neurosci Lett (2004) 1.14
Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res (Hoboken) (2011) 1.14
Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav Immun (2007) 1.13
Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome. Eur J Pain (2008) 1.13
Cutaneous neuropathy in Parkinson's disease: a window into brain pathology. Acta Neuropathol (2014) 1.12
Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve (2008) 1.12
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol (2011) 1.11
TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain (2007) 1.11
Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci (2002) 1.08
Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain (2013) 1.08
Physiological properties of spinal lamina II GABAergic neurons in mice following peripheral nerve injury. J Physiol (2006) 1.08
Patients with Fabry disease after enzyme replacement therapy dose reduction versus treatment switch. J Am Soc Nephrol (2014) 1.07
Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett (2008) 1.06
Differences in inflammatory pain in nNOS-, iNOS- and eNOS-deficient mice. Eur J Pain (2007) 1.05
Absence of thermal hyperalgesia in serotonin transporter-deficient mice. J Neurosci (2003) 1.05
Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline. Ger Med Sci (2008) 1.03
Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury. J Neurosci (2012) 1.02
Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol (2004) 1.02
Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat. Exp Neurol (2004) 1.01
Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J Neurosci (2004) 1.00
Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice. Mol Pain (2010) 1.00
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study). J Peripher Nerv Syst (2013) 1.00
The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs (2012) 1.00
A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis Rheum (2008) 0.98
Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther (2014) 0.96
Human stiff-person syndrome IgG induces anxious behavior in rats. PLoS One (2011) 0.95
Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A (2012) 0.95
Fighting off pain with resolvins. Nat Med (2010) 0.95
Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol (2003) 0.95
Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF. Neuropharmacology (2007) 0.95
The role of mitogen-activated protein kinase (MAPK) in morphine tolerance and dependence. Mol Neurobiol (2009) 0.94
Anticytokine therapy in neuropathic pain management. Expert Rev Neurother (2007) 0.93
Characterization of pain in fabry disease. Clin J Pain (2014) 0.92
Analysis of myelinated fibers in human skin biopsies of patients with neuropathies. J Neurol (2012) 0.92
Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase. Neurobiol Dis (2008) 0.91
Magnetic resonance neurography for the diagnosis of extrapelvic sciatic endometriosis. Fertil Steril (2010) 0.91
Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing. J Peripher Nerv Syst (2006) 0.91
Altered pain behavior and regeneration after nerve injury in TNF receptor deficient mice. J Peripher Nerv Syst (2006) 0.91
Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: comparison of different diagnostic modalities. Eur J Pain (2008) 0.91
Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge. Am J Med (2010) 0.90
Early cytokine gene expression in mouse CNS after peripheral nerve lesion. Neurosci Lett (2008) 0.90
Assessment of nerve degeneration by gadofluorine M-enhanced magnetic resonance imaging. Ann Neurol (2005) 0.90
Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve. Exp Neurol (2010) 0.89
Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine. J Neural Transm (Vienna) (2008) 0.89
Etiology of small-fiber neuropathy. J Peripher Nerv Syst (2009) 0.89
Epidermal innervation in type 1 diabetic patients: a 2.5-year prospective study after simultaneous pancreas/kidney transplantation. Diabetes Care (2008) 0.88
Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev (2013) 0.88
Psychophysics, flare, and neurosecretory function in human pain models: capsaicin versus electrically evoked pain. J Pain (2007) 0.88
Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy. Pain (2007) 0.88
Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin-transporter. Eur J Pain (2008) 0.88
Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control study. BMC Neurol (2013) 0.87
Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology (Oxford) (2010) 0.87
Interdisciplinary approach towards female patients with Fabry disease. Eur J Clin Invest (2011) 0.86
Human IgG directed against amphiphysin induces anxiety behavior in a rat model after intrathecal passive transfer. J Neural Transm (Vienna) (2012) 0.86
IL-4 deficiency is associated with mechanical hypersensitivity in mice. PLoS One (2011) 0.85
Up-regulation of spinal microglial Iba-1 expression persists after resolution of neuropathic pain hypersensitivity. Neurosci Lett (2013) 0.85
microRNAs in nociceptive circuits as predictors of future clinical applications. Front Mol Neurosci (2013) 0.85
Heterozygous P0 deficiency protects mice from vincristine-induced polyneuropathy. J Neurosci Res (2006) 0.84
Skin biopsy as an additional diagnostic tool in non-systemic vasculitic neuropathy. Acta Neuropathol (2010) 0.84
Tumor necrosis factor-alpha (TNF) regulates the expression of ICAM-1 predominantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve. Acta Neuropathol (2002) 0.84
Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies. J Neurol (2014) 0.84
The cutaneous nerve biopsy: technical aspects, indications, and contribution. Handb Clin Neurol (2013) 0.83
Small-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin. J Peripher Nerv Syst (2006) 0.83
Disruption of nodal architecture in skin biopsies of patients with demyelinating neuropathies. J Peripher Nerv Syst (2013) 0.83
Lidocaine patch (5%) in treatment of persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trial. Anesthesiology (2013) 0.83
Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: involvement of inflammatory mediators. J Neurosci Res (2007) 0.83
Processing of nerve biopsies: a practical guide for neuropathologists. Clin Neuropathol (2011) 0.83
Serotonin transporter deficiency protects mice from mechanical allodynia and heat hyperalgesia in vincristine neuropathy. Neurosci Lett (2011) 0.83
Neuronal nitric oxide synthase (NOS-I) knockout increases the survival rate of neural cells in the hippocampus independently of BDNF. Mol Cell Neurosci (2007) 0.82
Stiff person-syndrome IgG affects presynaptic GABAergic release mechanisms. J Neural Transm (Vienna) (2014) 0.82